Related Experiment Video
Updated: Jan 31, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
Honorine Lebraud1, Olga Surova1,2, Aurélie Courtin1
1Astex Pharmaceuticals , 436 Cambridge Science Park , Cambridge , CB4 0QA , UK . Email: honorine.lebraud@astx.com ;
Abstract:
Target engagement is a key concept in drug discovery and its direct measurement can provide a quantitative understanding of drug efficacy and/or toxicity. Failure to demonstrate target occupancy in relevant cells and tissues has been recognised as a contributing factor to the low success rate of clinical drug development. Several techniques are emerging to quantify target engagement in cells; however, in situ measurements remain challenging, mainly due to technical limitations. Here, we report the development of a non-covalent clickable probe, based on SCH772984, a slow off-rate ERK1/2 inhibitor, which enabled efficient pull down of ERK1/2 protein via click reaction with tetrazine tagged agarose beads. This was used in a competition setting to measure relative target occupancy by selected ERK1/2 inhibitors. As a reference we used the cellular thermal shift assay, a label-free biophysical assay relying solely on ligand-induced thermodynamic stabilization of proteins. To validate the EC50 values measured by both methods, the results were compared with IC50 data for the phosphorylation of RSK, a downstream substrate of ERK1/2 used as a functional biomarker of ERK1/2 inhibition. We showed that a slow off-rate reversible probe can be used to efficiently pull down cellular proteins, significantly extending the potential of the approach beyond the need for covalent or photoaffinity warheads.
Insights
Researchers developed a novel clickable probe to measure target engagement for ERK1/2 inhibitors in cells. This method allows for efficient protein pull-down, aiding drug discovery and development.
Area of Science:
- Drug Discovery and Development
- Chemical Biology
- Molecular Pharmacology
Background:
- Target engagement measurement is crucial for drug efficacy and toxicity assessment.
- Low success rates in clinical drug development are partly due to inadequate target occupancy data.
- Quantifying target engagement in situ remains a significant technical challenge.
Purpose of the Study:
- To develop a novel non-covalent clickable probe for measuring target engagement of ERK1/2 inhibitors.
- To enable efficient in situ quantification of target occupancy in relevant cells.
- To validate the probe's performance against established methods like cellular thermal shift assay.
Main Methods:
- Development of a clickable probe based on the slow off-rate ERK1/2 inhibitor SCH772984.
- Utilizing click chemistry with tetrazine-tagged agarose beads for ERK1/2 protein pull-down.
- Employing a competition assay to determine relative target occupancy by inhibitors.
- Comparison with cellular thermal shift assay (CTSA) and functional RSK phosphorylation inhibition.
Main Results:
- The developed probe successfully enabled efficient pull-down of ERK1/2 protein from cells.
- The probe facilitated the measurement of relative target occupancy for various ERK1/2 inhibitors.
- Results from the probe assay correlated well with CTSA and functional inhibition data (RSK phosphorylation).
Conclusions:
- A slow off-rate reversible probe can be effectively used for cellular protein pull-down.
- This approach extends target engagement measurement capabilities beyond covalent or photoaffinity probes.
- The developed method offers a valuable tool for quantitative target engagement studies in drug discovery.
Related Concept Videos
Gene Evolution - Fast or Slow?
In contrast, regions which code...
Gene Evolution - Fast or Slow?
Reaction Rate
The mathematical representation of the change in the concentration of reactants and products, over time, is the rate...
Concentration and Rate Law
For example, in a generic reaction aA + bB ⟶ products, where a and b are stoichiometric coefficients, the rate law can be written as:
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Rate-Determining Steps
In a multistep reaction mechanism, one of the elementary steps progresses significantly slower than the others. This slowest step is called the rate-limiting step (or rate-determining step). A reaction cannot proceed faster than its slowest step, and hence, the rate-determining step limits the overall reaction rate.
The concept of rate-determining step can be understood from the analogy of a 4-lane freeway with a short-stretch of traffic-bottleneck caused due to...

